Disease Progression Suppliers Serving USA

Bluejay Diagnostics, Inc. is developing easy-to-use, near patient medical diagnostics tests. Bluejay Diagnostics is focused on improving patient outcomes through a more cost efficient, rapid, near patient product for triage, diagnosis, and ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve care throughout the patient journey. We ask the right questions and provide answers that give physicians and patients a clearer ...

At QURE, we believe better healthcare is achieved through open collaboration, objective insights, and unrelenting dedication to research for better care practices. Since 2012, our driving passion has been helping the world's brightest professionals, ...

MR Solutions is at the forefront of MRI technology, particularly in the domain of cryogen-free superconducting MRI systems. Their innovations range from 3T to 9.4T, featuring dry magnets that eliminate the need for liquid helium, which not only ...

Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...

Cognoptix is developing a simple, innovative, non-invasive beta amyloid eye scanning test for use in adult patients being evaluated for Alzheimer’s Disease to aid in early diagnosis of this complex and devastating ...

Resoundant, Inc. is a medical technology company founded by Mayo Foundation for Medical Education and Research and is located in Rochester, MN. Resoundant is dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance ...

Neuroscience researchers throughout the world have used Event Related Potential (ERP) and quantitative electroencephalograph (qEEG) methods to evaluate a wide range of cognitive disorders, including Alzheimer’s disease and concussion/mTBI. ...

Guangzhou Wondfo Biotech Co., Ltd., headquartered in Guangzhou science city, has been focusing on the R&D, production, sales and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic ...

A global leader in interventional pulmonology, planning tools, and treatments for obstructive lung disease. Based in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is the maker of the Zephyr Endobronchial Valve. The Zephyr® Valve was ...

Accelerating Discovery in CNS, Cardiometabolic and Inflammatory Disease. We support our clients to achieve more in their target & biomarker programs. Our expertise, curated & disease enriched clinco-omic cohorts, tools and applications for insight ...

Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs, announced merger with AVROBIO, Inc. The combined company will ...

Addison Biological Laboratory, Inc. is a Fayette, MO based manufacturer and marketer of exclusive veterinary technologies. For over a third of a century, J. Bruce Addison, president and founder, has been recognized as a leader in veterinary ...

A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for ...

At Adiso, we create medicines to treat inflammatory diseases, improving the lives of patients and their families. Current treatment paradigms are far too often either inadequate to halt disease progression or burden the patient with significant ...

Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...

By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...

Manus Neurodynamica is revolutionising health care management by developing and patenting neuroscience technologies that record recognised biomarkers of neuromotor impairments which can radically improve patient diagnosis and disease monitoring. Our ...